Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic and tricyclic compounds as KAT II inhibitors

Bicyclic and tricyclic compounds as KAT II inhibitors

US Patent 8183238 · Granted May 22, 2012

Estimated economic value: $139,115,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating COVID-192025
Combinations for treatment of NAFLD/NASH and related diseases2025
Metabolically stable prodrugs2025
Compounds and method of treating COVID-192025
Pyrazolo[1,5-a]pyrazin-4-yl derivatives2024
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl a2024
Tricyclic compounds and their use as phosphodiesterase inhibitors2024
Heteroaromatic compounds and their use as dopamine D1 ligands2024
Compounds and methods for the treatment of COVID-192024
Azalactam compounds as HPK1 inhibitors2023
Nitrile-containing antiviral compounds2023
Nitrile-containing antiviral compounds2023